Tags

Type your tag names separated by a space and hit enter

[Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
Tijdschr Gerontol Geriatr. 2005 Jul; 36(3):122-6.TG

Abstract

Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands. Dementia affects 195,000 patients of 65 years and older in The Netherlands currently. Rivastigmine and galantamine, both cholinesterase inhibitors, and memantine, an NMDA (N-methyl-D-aspartate) antagonist, are licensed for the treatment of AD. In clinical practice, these drugs have limited effects on cognitive and other symptoms of dementia. We describe the practical care of some patients treated with these drugs and discuss the pros and cons of pharmacotherapy in AD. Extensive knowledge of the drugs, other treatment options and of dementia are necessary for good clinical practice in the treatment of these patients and the counselling of their caregivers.

Authors+Show Affiliations

Geheugenpolikliniek Slingeland Ziekenhuis, Kruisbergseweg 25, 7009 BL Doetinchem c.scholzel@slingeland.nlNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

dut

PubMed ID

16078659

Citation

Schölzel-Dorenbos, C J M., and Werkgroep Klinische GerontoFarmacologie. "[Pharmacological Therapy in Alzheimer's Disease. Current Clinical Practice in the Netherlands]." Tijdschrift Voor Gerontologie En Geriatrie, vol. 36, no. 3, 2005, pp. 122-6.
Schölzel-Dorenbos CJ, Werkgroep Klinische GerontoFarmacologie. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. Tijdschr Gerontol Geriatr. 2005;36(3):122-6.
Schölzel-Dorenbos, C. J. (2005). [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. Tijdschrift Voor Gerontologie En Geriatrie, 36(3), 122-6.
Schölzel-Dorenbos CJ, Werkgroep Klinische GerontoFarmacologie. [Pharmacological Therapy in Alzheimer's Disease. Current Clinical Practice in the Netherlands]. Tijdschr Gerontol Geriatr. 2005;36(3):122-6. PubMed PMID: 16078659.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. AU - Schölzel-Dorenbos,C J M, AU - ,, PY - 2005/8/5/pubmed PY - 2005/9/7/medline PY - 2005/8/5/entrez SP - 122 EP - 6 JF - Tijdschrift voor gerontologie en geriatrie JO - Tijdschr Gerontol Geriatr VL - 36 IS - 3 N2 - Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands. Dementia affects 195,000 patients of 65 years and older in The Netherlands currently. Rivastigmine and galantamine, both cholinesterase inhibitors, and memantine, an NMDA (N-methyl-D-aspartate) antagonist, are licensed for the treatment of AD. In clinical practice, these drugs have limited effects on cognitive and other symptoms of dementia. We describe the practical care of some patients treated with these drugs and discuss the pros and cons of pharmacotherapy in AD. Extensive knowledge of the drugs, other treatment options and of dementia are necessary for good clinical practice in the treatment of these patients and the counselling of their caregivers. SN - 0167-9228 UR - https://www.unboundmedicine.com/medline/citation/16078659/[Pharmacological_therapy_in_Alzheimer's_disease__Current_clinical_practice_in_The_Netherlands]_ L2 - https://medlineplus.gov/alzheimersdisease.html DB - PRIME DP - Unbound Medicine ER -